By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lab21 today announced it has acquired fungal molecular diagnostic firm Myconostica for an undisclosed amount.

The deal will expand Lab21's portfolio of diagnostics and will provide it with its first nucleic acid-based assays. It also provides Lab21 with manufacturing capabilities to develop and produce a range of new biomarker assays, the Cambridge, UK-based firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.